Faculty Opinions recommendation of Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1127135.584282 ◽

2008 ◽

Author(s):

Christopher Ormandy

Keyword(s):

Oestrogen Receptor

Download Full-text

A phase III trial to determine the activity and safety of fulvestrant (Faslodex®) in premenopausal women with oestrogen-receptor positive breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80305-7 ◽

2002 ◽

Vol 38 (11) ◽

pp. S97 ◽

Author(s):

J Robertson

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Premenopausal Women ◽

Phase Iii ◽

Phase Iii Trial ◽

Positive Breast Cancer

Download Full-text

P1215 Short-term transdermal oestradiol enhances nitric oxide synthase III and oestrogen receptor mRNA expression in arteries of women with coronary artery disease

European Heart Journal ◽

10.1016/s0195-668x(03)94507-6 ◽

2003 ◽

Vol 24 (5) ◽

pp. 229

Author(s):

M SITGES

Keyword(s):

Nitric Oxide ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Nitric Oxide Synthase ◽

Mrna Expression ◽

Oestrogen Receptor ◽

Receptor Mrna ◽

Artery Disease ◽

Download Full-text

CYTOPLASMIC OESTROGEN RECEPTOR REPLENISHMENT: OESTROGENS VERSUS ANTI-OESTROGENS

Acta Endocrinologica ◽

10.1530/acta.0.0890599 ◽

1978 ◽

Vol 89 (3) ◽

pp. 599-611 ◽

Author(s):

L. J. Baudendistel ◽

M. F. Ruh ◽

E. M. Nadel ◽

T. S. Ruh

Keyword(s):

Oestrogen Receptor

Download Full-text

Genetic variants at the Wnt/[beta]-catenin and oestrogen receptor signalling pathways are associated with low bone mineral density in dancers

Bone Abstracts ◽

10.1530/boneabs.5.p238 ◽

2016 ◽

Author(s):

Tania Amorim ◽

Cecilia Duraes ◽

Jose Maia ◽

Machado Jose Carlos ◽

Luisa Nogueira ◽

...

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Genetic Variants ◽

Oestrogen Receptor ◽

Signalling Pathways ◽

Beta Catenin ◽

Mineral Density ◽

Receptor Signalling ◽

Low Bone Mineral Density

Download Full-text

Bisphenol A-induced epithelial-mesenchymal transition was reversed with a phytoestrogen, genistein via oestrogen receptor and downregulation of transforming growth factor-beta signalling pathway

Endocrine Abstracts ◽

10.1530/endoabs.37.oc2.5 ◽

2015 ◽

Author(s):

Ye-Seul Kim ◽

Kyung-A Hwang ◽

Kyung-Chul Choi

Keyword(s):

Growth Factor ◽

Bisphenol A ◽

Transforming Growth Factor Beta ◽

Oestrogen Receptor ◽

Transforming Growth Factor ◽

Epithelial Mesenchymal Transition ◽

Signalling Pathway ◽

Mesenchymal Transition ◽

Growth Factor Beta

Download Full-text

Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma

Endocrine Abstracts ◽

10.1530/endoabs.37.oc8.5 ◽

2015 ◽

Author(s):

Mitchell Lawrence ◽

Ruth Pidsley ◽

Stuart Ellem ◽

Luc Furic ◽

Shalima Nair ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Progression ◽

Oestrogen Receptor ◽

Prostate Cancer Progression ◽

Oestrogen Receptor Α

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793525549 ◽

2016 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793480576 ◽

2013 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Automated Quantification of Extranuclear Oestrogen Receptor Alpha Using Phosphor-Integrated Dots for Predicting Endocrine Therapy Resistance in Hormone Receptor-Positive HER2-Negative Breast Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3339476 ◽

2019 ◽

Author(s):

Zhaorong Guo ◽

Hiroshi Tada ◽

Narufumi Kitamura ◽

Yoh Hamada ◽

Minoru Miyashita ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Oestrogen Receptor ◽

Therapy Resistance ◽

Endocrine Therapy Resistance ◽

Receptor Alpha ◽

Hormone Receptor Positive ◽

Oestrogen Receptor Alpha ◽

Automated Quantification

Download Full-text

Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database

SSRN Electronic Journal ◽

10.2139/ssrn.3668352 ◽

2020 ◽

Author(s):

Taobo Hu ◽

Mengping Long ◽

Xiaojie Zhou ◽

Shu Wang

Keyword(s):

Breast Cancer ◽

Natural History ◽

Oestrogen Receptor ◽

Seer Database ◽

Oestrogen Receptor Status ◽

Receptor Status ◽

Nodal Stage ◽

Download Full-text